InvestorsHub Logo
Followers 37
Posts 7135
Boards Moderated 1
Alias Born 09/06/2014

Re: 2themoon1 post# 15379

Saturday, 12/02/2023 8:14:25 AM

Saturday, December 02, 2023 8:14:25 AM

Post# of 15659
As I'm sure you saw in the 11/20 PR, SMI says they've completed those last 12 patients and:

Shandong Yaohua Medical Instrument Corporation (SMI) intends to analyze the study results with the participating doctors and file them with the NMPA within the next 90 days. The filing triggers purchase order payments to Guided Therapeutics of approximately $2.2 Million, with additional significant orders for devices and disposables in 2024 and beyond.

Will SMI pay $2.2 million to Guided on or before 02/20/2024? I remain skeptical. The word "intends" is Safe Harbor language at its finest.

Will SMI pay that $2.2 million sometime in 2024? Maybe.

It's good to finally see some details about that Chinese study and see proof that it wasn't just SMI trying to run a study on their own. It's difficult to do DD on the doctors who participated in the Chinese study, but Kong Beihua and Sui Long, the doctors who led the study, appear to be accomplished researchers in China (see links below). which means the Chinese study is probably legit and Guided can submit that 450-patient study to the USFDA when they finally submit their own clinical results. Can't hurt.

https://www.qiluhospital.com/en/index.php?m=content&c=index&a=show&catid=15&id=765

https://www.aminer.org/profile/kong-beihua/56141fbe45ce1e5963332014

https://www.aminer.org/profile/sui-long/5431101fdabfae8cc1bff7ee
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News